Skip to main navigation Skip to search Skip to main content

Preoperative risk score for 90-day mortality after major liver resection

  • Sebastiaan Ceuppens*
  • , Pim B. Olthof
  • , Arthur K. E. Elfrink
  • , Stijn Franssen
  • , Rutger-Jan Swijnenburg
  • , Joost M. Klaase
  • , Maarten W. Nijkamp
  • , Frederik J. H. Hoogwater
  • , Andries E. Braat
  • , Jeroen Hagendoorn
  • , Wouter J. M. Derksen
  • , Peter B. van den Boezem
  • , Paul D. Gobardhan
  • , Marcel den Dulk
  • , Maxime J. L. Dewulf
  • , Mike S. L. Liem
  • , Wouter K. G. Leclercq
  • , Eric J. T. Belt
  • , Koert F. D. Kuhlmann
  • , Niels F. M. Kok
  • Hendrik A. Marsman, Dirk Jan Grünhagen, Joris I. Erdmann, Bas Groot Koerkamp
*Corresponding author for this work
  • Erasmus University Rotterdam
  • University of Amsterdam
  • Scientific Bureau
  • University of Groningen
  • Leiden University
  • Utrecht University
  • St. Antonius Ziekenhuis
  • Radboud University Nijmegen
  • Amphia Medical Center
  • Maastricht University
  • Medisch Spectrum Twente
  • Maxima Medical Centre
  • Albert Schweitzer Ziekenhuis
  • Netherlands Cancer Institute
  • Onze Lieve Vrouwe Gasthuis

Research output: Contribution to journalArticleAcademicpeer-review

18 Downloads (Pure)

Abstract

Background: Major liver resection is frequently performed for primary and secondary liver tumors. However, 90-day mortality rates can exceed 10% in high-risk patients. This study aimed to develop a preoperative risk score for postoperative mortality after major liver resection. Methods: All major liver resections between 2014 and 2019 in 2 Dutch tertiary referral centers were identified. A validation cohort consisted of all consecutive patients who underwent a major liver resection in the nationwide Dutch Hepato Biliary Audit from 2014 to 2020. Multivariate logistic regression was used to identify prognostic factors and develop a mortality risk score. Results: Major liver resection was performed in 513 patients, of whom 238 (46.4%) had a primary liver cancer, and in 148 patients (28.8%), a hepaticojejunostomy was performed; 90-day mortality occurred in 56 patients (10.8%). Mortality was independently predicted by 5 risk factors: age ≥ 65 years, diabetes mellitus type 2, diagnosis of primary liver cancer, American Society of Anesthesiologists ≥ 3, and extended hemihepatectomy. A risk score with 1 point assigned to each risk factor showed good discrimination (area under the curve [AUC], 0.77; 95% CI, 0.71–0.83). The predicted 90-day mortality was 3.5% for low-risk (0 or 1 points; 53.8% of all patients), 11.1% for intermediate-risk (2 points; 25.3%), and 29.7% for high-risk patients (3–5 points; 20.9%). External validation in the nationwide cohort with 1617 patients showed similar concordance (AUC, 0.69; 95% CI, 0.64–0.75). Conclusion: The proposed and validated risk score can aid in shared decision making.
Original languageEnglish
Article number102064
JournalJournal of gastrointestinal surgery
Volume29
Issue number6
DOIs
Publication statusPublished - 1 Jun 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 90-Day mortality
  • Cancer
  • Major liver resection
  • Risk score

Fingerprint

Dive into the research topics of 'Preoperative risk score for 90-day mortality after major liver resection'. Together they form a unique fingerprint.

Cite this